Market Closed -
Xetra
11:35:31 2024-05-31 am EDT
|
5-day change
|
1st Jan Change
|
39.18
EUR
|
+0.31%
|
|
+0.46%
|
+3.21%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
19,672
|
19,974
|
16,742
|
8,970
|
11,138
|
11,496
|
-
|
-
|
Enterprise Value (EV)
1 |
32,447
|
31,272
|
28,580
|
20,909
|
21,898
|
21,423
|
20,477
|
19,469
|
P/E ratio
|
16.7
x
|
17.2
x
|
17.3
x
|
13.3
x
|
22.3
x
|
17.2
x
|
12
x
|
9.98
x
|
Yield
|
1.82%
|
1.96%
|
2.36%
|
3.66%
|
3.13%
|
2.75%
|
3.33%
|
3.85%
|
Capitalization / Revenue
|
1.13
x
|
1.12
x
|
0.95
x
|
0.46
x
|
0.57
x
|
0.59
x
|
0.57
x
|
0.54
x
|
EV / Revenue
|
1.86
x
|
1.75
x
|
1.62
x
|
1.08
x
|
1.13
x
|
1.1
x
|
1.01
x
|
0.92
x
|
EV / EBITDA
|
8.4
x
|
7.65
x
|
8.22
x
|
6.24
x
|
7.02
x
|
6.34
x
|
5.51
x
|
4.89
x
|
EV / FCF
|
22.5
x
|
9.78
x
|
17.2
x
|
14.1
x
|
11.2
x
|
11.9
x
|
10.7
x
|
10.7
x
|
FCF Yield
|
4.44%
|
10.2%
|
5.81%
|
7.08%
|
8.95%
|
8.39%
|
9.38%
|
9.37%
|
Price to Book
|
1.67
x
|
1.78
x
|
1.32
x
|
0.64
x
|
0.75
x
|
0.81
x
|
0.78
x
|
0.75
x
|
Nbr of stocks (in thousands)
|
298,249
|
292,869
|
292,994
|
293,413
|
293,413
|
293,413
|
-
|
-
|
Reference price
2 |
65.96
|
68.20
|
57.14
|
30.57
|
37.96
|
39.18
|
39.18
|
39.18
|
Announcement Date
|
2/20/20
|
2/23/21
|
2/22/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
17,477
|
17,859
|
17,619
|
19,398
|
19,454
|
19,559
|
20,298
|
21,167
|
EBITDA
1 |
3,863
|
4,090
|
3,476
|
3,350
|
3,121
|
3,377
|
3,716
|
3,979
|
EBIT
1 |
2,270
|
2,304
|
1,852
|
1,512
|
1,369
|
1,673
|
2,044
|
2,295
|
Operating Margin
|
12.99%
|
12.9%
|
10.51%
|
7.79%
|
7.04%
|
8.55%
|
10.07%
|
10.84%
|
Earnings before Tax (EBT)
1 |
1,841
|
1,936
|
1,572
|
1,219
|
1,033
|
1,210
|
1,633
|
1,898
|
Net income
1 |
1,200
|
1,164
|
969.3
|
673.4
|
499
|
665.4
|
964.3
|
1,156
|
Net margin
|
6.87%
|
6.52%
|
5.5%
|
3.47%
|
2.57%
|
3.4%
|
4.75%
|
5.46%
|
EPS
2 |
3.960
|
3.960
|
3.310
|
2.300
|
1.700
|
2.275
|
3.259
|
3.925
|
Free Cash Flow
1 |
1,442
|
3,197
|
1,660
|
1,480
|
1,960
|
1,796
|
1,920
|
1,825
|
FCF margin
|
8.25%
|
17.9%
|
9.42%
|
7.63%
|
10.08%
|
9.19%
|
9.46%
|
8.62%
|
FCF Conversion (EBITDA)
|
37.33%
|
78.17%
|
47.76%
|
44.18%
|
62.8%
|
53.19%
|
51.68%
|
45.86%
|
FCF Conversion (Net income)
|
120.18%
|
274.57%
|
171.26%
|
219.78%
|
392.79%
|
269.97%
|
199.13%
|
157.82%
|
Dividend per Share
2 |
1.200
|
1.340
|
1.350
|
1.120
|
1.190
|
1.078
|
1.304
|
1.508
|
Announcement Date
|
2/20/20
|
2/23/21
|
2/22/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
4,647
|
4,548
|
4,757
|
5,096
|
4,997
|
4,704
|
4,825
|
4,936
|
4,988
|
4,725
|
4,824
|
4,975
|
4,976
|
-
|
-
|
EBITDA
1 |
895.4
|
767
|
763
|
973.6
|
846.6
|
698.8
|
790.8
|
778.3
|
854
|
-
|
750.5
|
778.1
|
863.2
|
-
|
-
|
EBIT
1 |
449.2
|
348
|
341
|
471.6
|
351.9
|
260.9
|
357
|
324
|
428
|
246
|
430.8
|
445.5
|
472.4
|
-
|
-
|
Operating Margin
|
9.67%
|
7.65%
|
7.17%
|
9.25%
|
7.04%
|
5.55%
|
7.4%
|
6.56%
|
8.58%
|
5.21%
|
8.93%
|
8.95%
|
9.49%
|
-
|
-
|
Earnings before Tax (EBT)
|
382.4
|
278.6
|
268.9
|
395.2
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Net income
|
228.7
|
157
|
147
|
230.1
|
138.8
|
86.36
|
140
|
84
|
188
|
71
|
-
|
-
|
-
|
-
|
-
|
Net margin
|
4.92%
|
3.45%
|
3.09%
|
4.52%
|
2.78%
|
1.84%
|
2.9%
|
1.7%
|
3.77%
|
1.5%
|
-
|
-
|
-
|
-
|
-
|
EPS
|
0.7800
|
0.5400
|
0.5000
|
0.7800
|
0.4800
|
0.2900
|
0.4800
|
0.2900
|
0.6400
|
0.2400
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
1.350
|
-
|
-
|
-
|
1.120
|
-
|
-
|
-
|
1.190
|
-
|
-
|
-
|
0.7387
|
-
|
-
|
Announcement Date
|
2/22/22
|
5/4/22
|
7/28/22
|
10/31/22
|
2/21/23
|
5/9/23
|
8/2/23
|
11/1/23
|
2/20/24
|
5/7/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
12,775
|
11,298
|
11,838
|
11,939
|
10,760
|
9,927
|
8,981
|
7,973
|
Net Cash position
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
3.307
x
|
2.762
x
|
3.406
x
|
3.564
x
|
3.448
x
|
2.939
x
|
2.417
x
|
2.004
x
|
Free Cash Flow
1 |
1,442
|
3,197
|
1,660
|
1,480
|
1,960
|
1,797
|
1,920
|
1,825
|
ROE (net income / shareholders' equity)
|
11.5%
|
11.7%
|
7.37%
|
5.05%
|
4.99%
|
5.58%
|
6.95%
|
7.83%
|
ROA (Net income/ Total Assets)
|
4.06%
|
3.6%
|
2.93%
|
1.92%
|
2.17%
|
2%
|
2.69%
|
3.31%
|
Assets
1 |
29,589
|
32,308
|
33,038
|
35,060
|
22,998
|
33,308
|
35,833
|
34,972
|
Book Value Per Share
2 |
39.50
|
38.30
|
43.30
|
47.70
|
50.50
|
48.30
|
50.00
|
52.40
|
Cash Flow per Share
2 |
8.480
|
14.40
|
8.500
|
7.390
|
8.960
|
6.630
|
7.220
|
7.770
|
Capex
1 |
1,125
|
1,036
|
829
|
687
|
669
|
805
|
914
|
1,006
|
Capex / Sales
|
6.44%
|
5.8%
|
4.71%
|
3.54%
|
3.44%
|
4.11%
|
4.5%
|
4.75%
|
Announcement Date
|
2/20/20
|
2/23/21
|
2/22/22
|
2/21/23
|
2/20/24
|
-
|
-
|
-
|
Last Close Price
39.18
EUR Average target price
39.92
EUR Spread / Average Target +1.89% Consensus |
1st Jan change
|
Capi.
|
---|
| +3.21% | 12.47B | | +25.52% | 88.99B | | -24.52% | 74.82B | | -5.56% | 25.03B | | +4.31% | 17.88B | | -14.25% | 16.43B | | +2.97% | 15.77B | | +70.11% | 13.09B | | +79.20% | 13.21B | | +40.44% | 12.9B |
Other Healthcare Facilities & Services
|